A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in the United States.
Michael Frank MørupSteven M KymesDaniel Oudin ÅstrømPublished in: PloS one (2020)
The results suggests that prevalence of TRS may be somewhat lower than the 30% often reported, however this is highly dependent on the definition of treatment resistance. Methods such as this may help answer epidemiological and health policy questions as well as test the influence of key underlying assumptions.